These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35007136)

  • 1. Pseudomonas aeruginosa Oligoribonuclease Controls Tolerance to Polymyxin B by Regulating Pel Exopolysaccharide Production.
    Yang B; Jiang Y; Jin Y; Bai F; Cheng Z; Wu W
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0207221. PubMed ID: 35007136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligoribonuclease Contributes to Tolerance to Aminoglycoside and β-Lactam Antibiotics by Regulating KatA in Pseudomonas aeruginosa.
    Xia B; Li M; Tian Z; Chen G; Liu C; Xia Y; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936107
    [No Abstract]   [Full Text] [Related]  

  • 3. MvfR Controls Tolerance to Polymyxin B by Regulating
    Yang F; Zhou Y; Bai Y; Pan X; Ha UH; Cheng Z; Wu W; Jin Y; Bai F
    Microbiol Spectr; 2023 Jun; 11(3):e0042623. PubMed ID: 37039709
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Janet-Maitre M; Job V; Bour M; Robert-Genthon M; Brugière S; Triponney P; Cobessi D; Couté Y; Jeannot K; Attrée I
    mBio; 2024 Mar; 15(3):e0221123. PubMed ID: 38345374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoribonuclease is the primary degradative enzyme for pGpG in Pseudomonas aeruginosa that is required for cyclic-di-GMP turnover.
    Orr MW; Donaldson GP; Severin GB; Wang J; Sintim HO; Waters CM; Lee VT
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):E5048-57. PubMed ID: 26305945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa Oligoribonuclease Contributes to Tolerance to Ciprofloxacin by Regulating Pyocin Biosynthesis.
    Chen F; Chen G; Liu Y; Jin Y; Cheng Z; Liu Y; Yang L; Jin S; Wu W
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Subset of Exoribonucleases Serve as Degradative Enzymes for pGpG in c-di-GMP Signaling.
    Orr MW; Weiss CA; Severin GB; Turdiev H; Kim SK; Turdiev A; Liu K; Tu BP; Waters CM; Winkler WC; Lee VT
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa.
    Cohen D; Mechold U; Nevenzal H; Yarmiyhu Y; Randall TE; Bay DC; Rich JD; Parsek MR; Kaever V; Harrison JJ; Banin E
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11359-64. PubMed ID: 26305928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pel Polysaccharide Biosynthesis Requires an Inner Membrane Complex Comprised of PelD, PelE, PelF, and PelG.
    Whitfield GB; Marmont LS; Ostaszewski A; Rich JD; Whitney JC; Parsek MR; Harrison JJ; Howell PL
    J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31988082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa.
    Qi L; Liang R; Duan J; Song S; Pan Y; Liu H; Zhu M; Li L
    J Antibiot (Tokyo); 2022 Oct; 75(10):567-575. PubMed ID: 35999263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel PhoP-PhoQ Regulated Genes That Contribute to Polymyxin B Tolerance in
    Yang B; Liu C; Pan X; Fu W; Fan Z; Jin Y; Bai F; Cheng Z; Wu W
    Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33572426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin-Induced Lipid A Deacylation in Pseudomonas aeruginosa Perturbs Polymyxin Penetration and Confers High-Level Resistance.
    Han ML; Velkov T; Zhu Y; Roberts KD; Le Brun AP; Chow SH; Gutu AD; Moskowitz SM; Shen HH; Li J
    ACS Chem Biol; 2018 Jan; 13(1):121-130. PubMed ID: 29182311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligoribonuclease mediates high adaptability of P. aeruginosa through metabolic conversion.
    Yang L; Wang L; Wang M; Bajinka O; Wu G; Qin L; Tan Y
    BMC Microbiol; 2024 Jan; 24(1):25. PubMed ID: 38238663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
    Barrow K; Kwon DH
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
    Gutu AD; Sgambati N; Strasbourger P; Brannon MK; Jacobs MA; Haugen E; Kaul RK; Johansen HK; Høiby N; Moskowitz SM
    Antimicrob Agents Chemother; 2013 May; 57(5):2204-15. PubMed ID: 23459479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.
    Poole K; Lau CH; Gilmour C; Hao Y; Lam JS
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7276-89. PubMed ID: 26369970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
    Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.